284 related articles for article (PubMed ID: 16554021)
1. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
[TBL] [Abstract][Full Text] [Related]
2. Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis.
Perez-Pinera P; Berenson JR; Deuel TF
Curr Opin Hematol; 2008 May; 15(3):210-4. PubMed ID: 18391787
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
[TBL] [Abstract][Full Text] [Related]
4. Pleiotrophin induces formation of functional neovasculature in vivo.
Christman KL; Fang Q; Kim AJ; Sievers RE; Fok HH; Candia AF; Colley KJ; Herradon G; Ezquerra L; Deuel TF; Lee RJ
Biochem Biophys Res Commun; 2005 Jul; 332(4):1146-52. PubMed ID: 15949466
[TBL] [Abstract][Full Text] [Related]
5. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway.
Deuel TF; Zhang N; Yeh HJ; Silos-Santiago I; Wang ZY
Arch Biochem Biophys; 2002 Jan; 397(2):162-71. PubMed ID: 11795867
[TBL] [Abstract][Full Text] [Related]
6. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
Malerczyk C; Schulte AM; Czubayko F; Bellon L; Macejak D; Riegel AT; Wellstein A
Gene Ther; 2005 Feb; 12(4):339-46. PubMed ID: 15496960
[TBL] [Abstract][Full Text] [Related]
8. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.
Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E
J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482
[TBL] [Abstract][Full Text] [Related]
9. Midkine, a newly discovered regulator of the renin-angiotensin pathway in mouse aorta: significance of the pleiotrophin/midkine developmental gene family in angiotensin II signaling.
Ezquerra L; Herradon G; Nguyen T; Silos-Santiago I; Deuel TF
Biochem Biophys Res Commun; 2005 Jul; 333(2):636-43. PubMed ID: 15979460
[TBL] [Abstract][Full Text] [Related]
10. Macrophages regulate the angiogenic switch in a mouse model of breast cancer.
Lin EY; Li JF; Gnatovskiy L; Deng Y; Zhu L; Grzesik DA; Qian H; Xue XN; Pollard JW
Cancer Res; 2006 Dec; 66(23):11238-46. PubMed ID: 17114237
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic switch as a molecular target of malignant tumors.
Tanaka S; Sugimachi K; Yamashita Y; Shirabe K; Shimada M; Wands JR; Sugimachi K
J Gastroenterol; 2003 Mar; 38 Suppl 15():93-7. PubMed ID: 12698880
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A
Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381
[TBL] [Abstract][Full Text] [Related]
13. Roles of pleiotrophin in tumor growth and angiogenesis.
Papadimitriou E; Mikelis C; Lampropoulou E; Koutsioumpa M; Theochari K; Tsirmoula S; Theodoropoulou C; Lamprou M; Sfaelou E; Vourtsis D; Boudouris P
Eur Cytokine Netw; 2009 Dec; 20(4):180-90. PubMed ID: 20167557
[TBL] [Abstract][Full Text] [Related]
14. Midkine and pleiotrophin in neural development and cancer.
Kadomatsu K; Muramatsu T
Cancer Lett; 2004 Feb; 204(2):127-43. PubMed ID: 15013213
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors.
Mitra SK; Mikolon D; Molina JE; Hsia DA; Hanson DA; Chi A; Lim ST; Bernard-Trifilo JA; Ilic D; Stupack DG; Cheresh DA; Schlaepfer DD
Oncogene; 2006 Sep; 25(44):5969-84. PubMed ID: 16682956
[TBL] [Abstract][Full Text] [Related]
16. Pleiotrophin is an important regulator of the renin-angiotensin system in mouse aorta.
Herradon G; Ezquerra L; Nguyen T; Vogt TF; Bronson R; Silos-Santiago I; Deuel TF
Biochem Biophys Res Commun; 2004 Nov; 324(3):1041-7. PubMed ID: 15485659
[TBL] [Abstract][Full Text] [Related]
17. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta.
Pariser H; Perez-Pinera P; Ezquerra L; Herradon G; Deuel TF
Biochem Biophys Res Commun; 2005 Sep; 335(1):232-9. PubMed ID: 16105548
[TBL] [Abstract][Full Text] [Related]
18. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
20. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
Perez-Pinera P; Chang Y; Deuel TF
Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
